Anika Therapeutics (ANIK), a small-cap biotech that’s turning its financials around, broke out of a base Thursday.
The stock jumped 2.27, or 5%, to 47.68, clearing the 47.34 buy point of a base-on-base pattern. Volume was nearly triple above average, a confirming signal for the breakout.